Tedatioxetine
 | |
 | |
| Systematic (IUPAC) name | |
|---|---|
|
4-{2-[(4-methylphenyl)sulfanyl]phenyl}piperidine | |
| Clinical data | |
| Legal status |
|
| Identifiers | |
| CAS Number |
508233-95-2  |
| ATC code | None |
| PubChem | CID 9878913 |
| ChemSpider |
8054590 |
| KEGG |
D10170  |
| Synonyms | Lu AA24530; Lu-AA-24530 |
| Chemical data | |
| Formula | C18H21NS |
| Molar mass | 283.43 g/mol |
| |
| |
| (what is this?) (verify) | |
Tedatioxetine (Lu AA24530) is an antidepressant that was discovered by scientists at Lundbeck; in 2007 Lundbeck and Takeda entered into a partnership that included tedatioxetine but was focused on another, more advanced Lundbeck drug candidate, vortioxetine.[1]
Tedatioxetine is reported to act as a triple reuptake inhibitor (5-HT > NE > DA) and 5-HT2A, 5-HT2C, 5-HT3 and α1A-adrenergic receptor antagonist.[2][3][4][5]
As of 2009, it was in phase II clinical trials for major depressive disorder,[5] but there have been no updates since then, and as of August 2013 it was no longer displayed on Lundbeck's product pipeline.[6][7]
See also
References
- ↑ Daniel Beaulieu for First Word Pharma. September 5th, 2007 Lundbeck, Takeda enter strategic alliance for mood disorder, anxiety drugs
- ↑ "Patent US20100144788 - 4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistant depression or residual symptoms in depression". Retrieved 7 April 2014.
- ↑ Stephen M. Stahl (19 May 2008). Depression and bipolar disorder: Stahl's essential psychopharmacology. Cambridge University Press. p. 206. ISBN 978-0-521-88663-5. Retrieved 22 November 2011.
- ↑ Ian P. Stolerman (30 August 2010). Encyclopedia of Psychopharmacology. Springer. p. 105. ISBN 978-3-540-68698-9. Retrieved 22 November 2011.
- 1 2 "Lu AA24530 shows positive results in major depressive disorder phase II study - FierceBiotech".
- ↑ "Pipeline of Lundbeck". Retrieved 25 August 2013.
- ↑ UK Medicines Information Tedatioxetine entry in UKMI. Page accessed January 20, 2016
External links
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Wednesday, January 20, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.